//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfileReplies
Loading...
We're hiring! šŸ§Ŗ TARGID @ KU Leuven is looking for a Laboratory Manager to coordinate and support cutting-edge research on gastrointestinal diseases. šŸ“Leuven | ā° Apply by Nov 4, 2025 šŸ”— kuleuven.be/personeel/jobsite/jobs/60566238 #KULeuven #Hiring #Research
Congratulations! Very well deserved!
NIM lab is growing! šŸ§ šŸ”¬ We are hiring a flow cytometry specialist, a bioinformatician and a post-doc candidate! Join us or help spread the word: - jobs.vib.be/j/113480/flo... - jobs.vib.be/j/113083/bio... - www.uantwerpen.be/en/jobs/vaca...
Proud promoter. Well done Gaia Zanell presenting our data on Complement in IBD @fibrotarget.bsky.social
Looking for reliable information on fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA! Download your copy šŸ‘‰ https://loom.ly/yW8mEBc
Every ā‚¬1 the EU invests in research can yield up to ā‚¬11 in growth by 2045. With ā‚¬43 billion from Horizon Europe, weā€™ve backed 15,000+ projects ā€“ from antibiotics to the transition. This year weā€™ll put in over ā‚¬7.3 billion to meet Europeā€™s challenges. For everyone to benefit ā†“ europa.eu/!WHpGGg
Delighted to join the International Conference on Complement Therapeutics @aegeanconf.bsky.social ā€” a fantastic setting to hear from pioneers like John Lambris on development of complement-targeted therapies. We will present our latest data on the role of complement in IBD @fibrotarget.bsky.social
Harvard redid its whole homepage to push back against the administrationā€™s demands. I mean, this is just a website but I think itā€™s kind of a great PR move: www.harvard.edu
April 2025 issue of Trends in Neurosciences: www.cell.com/issue/S0166-... Free featured articles & more: cell.com/trends/neuro... Cover article: ā€˜MicroRNA regulation of enteric nervous system development and diseaseā€™ by Holland et al., @wboesmans.bsky.social group www.cell.com/trends/neuro...
Fantastic story showcasing the full strength of @KU_Leuven ā€” from cutting-edge basic science to real-world exploitation. A true example of how academic excellence can drive meaningful impact on health! @kuleuvenuniversity.bsky.social